Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

20 treatments under study, led by Tramadol

Research Leaders

15 sponsors active, led by National Cancer Institute (NCI)

Related Conditions

Often studied with 20 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 11 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

9%

1 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (6)
Phase 2 (1)
Phase 3 (1)

Trial Status

Completed6
Unknown4
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 6 completed trials

Clinical Trials (11)

Research Network

Common Treatments

  • Tramadol1
  • Treatment With Novox Cup1
  • Kaloidon Plus1
  • Ketorolac1
  • Physical Activity Measure1

Active Sponsors

  • National Cancer Institute (NCI)1
  • University of Nebraska1
  • Neoneur LLC1
  • Royal Adelaide Hospital1
  • Agency for Healthcare Research and Quality (AHRQ)1

Top Investigators

Related Conditions

  • Periodontal Inflammation1
  • Opioid Dependence1
  • Scar Itching1
  • Cicatrix1
  • Wound Healing Disorder1

Activity Timeline